机构投资者在收入丰厚和股息提高之后,增加了Cencora公司的股权。 Institutional investors boosted holdings in Cencora, Inc., after strong earnings and a raised dividend.

Camden National Bank及其他机构投资者增加了在Cencora Inc.的股份,此前,该公司的Q4收入报告强劲,估计比EPS高出3.73美元。 Camden National Bank and other institutional investors increased their holdings in Cencora, Inc., following its strong Q4 earnings report, which beat estimates with $3.73 EPS. 该公司还将股息提高到季度0.55美元。 The company also raised its dividend to $0.55 quarterly. 来自Wells Fargo和JP摩根大通的分析员将其价格指标分别提高到251.00和301.0美元。 Analysts from Wells Fargo and JPMorgan Chase raised their price targets to $251.00 and $301.00, respectively. Cencora提供和分销药品,市场上限为49.36亿美元。 Cencora, which sources and distributes pharmaceuticals, has a market cap of $49.36 billion.